Researchers have developed an inclusive in vitro in vivo extrapolation (i-IVIVE) to predict ethnic differences in drug ...
18d
Pharmaceutical Technology on MSNFDA approves Mirum’s Ctexli for cerebrotendinous xanthomatosisMirum Pharmaceuticals’ Ctexli (chenodiol) has gained US Food and Drug Administration (FDA) approval for treating adults with cerebrotendinous xanthomatosis (CTX), a rare lipid storage disease. It is ...
The product will be launched in Q2 2025 for resistant pest control in rice, shallots, and other vegetable crops.
Interactions with drugs affecting cytochrome P450 isoenzymes. Assess the potential need for access to naloxone when initiating and renewing therapy. Consider prescribing naloxone based on risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results